Further studies on the potential use of sirolimus for the treatment of de noo tumors in immunosuppressed kidney transplant recipients with HNPCC are warranted.

• 在有HNPCC的肾移植患者；西罗莫司对新发肿瘤治疗的潜在作用要进一步研究.